Modern aspects of diagnosis and treatment of chronic cerebral ischemia. Application of naftidrofuryl

Abstract

Chronic cerebral ischemia (CCI) is one of the most common diagnoses in the national neurology, which is now completely absent in most countries and to a certain extent corresponds to vascular cognitive impairment (VCI) in modern foreign literature. The literature data and author's findings on the diagnosis and treatment of CCI are presented. Other diseases may often clinically simulate CCI (anxiety and depressive disorders, primary headaches, peripheral vestibulopathy, Alzheimer's disease) which unfortunately are poorly diagnosed in clinical practice, so patients do not receive effective treatment. Treatment of patients with CCI (VCI) should be focused on managing risk factors for stroke (cessation of smoking and alcohol abuse, sufficient physical activity), normalization of blood pressure (antihypertensive agents), reduction of blood cholesterol levels (statins), antithrombotic therapy (antiplatelet agents and anticoagulants), and administration of drugs that enhance cognitive function. There are findings on the use of naftidrofuryl (Dusopharm) in patients with cognitive impairment.

Keywords

• хроническая ишемия головного мозга
• дисциркуляторная энцефалопатия
• сосудистые когнитивные расстройства
• нафтидрофурил дузофарм
• chronic cerebral ischemia
• dyscirculatory encephalopathy
• vascular cognitive impairment
• naftidrofuryl
• dusopharm